Market Overview

Zogenix to Host Conference Call Following FDA Panel Meeting, Will Be at 6:30PM

Share:
Related ZGNX
Zogenix Announces New Efficacy Data from Long-Term Study of Low-Dose Fenfluramine for Treatment of Dravet Syndrome
Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study

Zogenix (NASDAQ: ZGNX) will host a conference call to discuss the outcome of the AADPAC meeting today, Friday, December 7, 2012 at 6:30 p.m. ET (3:30 p.m. PT). To participate, please dial (800) 299-9086 (U.S.) or (617) 786-2903 (International); participant passcode: 21970283.

Posted-In: News FDA

 

Related Articles (ZGNX)

Around the Web, We're Loving...